Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi Therapeutics (MGX) Asset Writedowns and Impairment (2023 - 2025)

Metagenomi (MGX) has disclosed Asset Writedowns and Impairment for 3 consecutive years, with $181000.0 as the latest value for Q2 2025.

  • Quarterly Asset Writedowns and Impairment fell 34.18% to $181000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $933000.0 through Sep 2025, up 206.91% year-over-year, with the annual reading at $1.0 million for FY2024, 4430.43% up from the prior year.
  • Asset Writedowns and Impairment for Q2 2025 was $181000.0 at Metagenomi, down from $752000.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $752000.0 in Q4 2024, with the low at $4000.0 in Q1 2024.
  • Average Asset Writedowns and Impairment over 3 years is $206166.7, with a median of $97500.0 recorded in 2023.
  • The sharpest move saw Asset Writedowns and Impairment soared 5271.43% in 2024, then crashed 34.18% in 2025.
  • Over 3 years, Asset Writedowns and Impairment stood at $14000.0 in 2023, then skyrocketed by 5271.43% to $752000.0 in 2024, then plummeted by 75.93% to $181000.0 in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $181000.0, $752000.0, and $11000.0 for Q2 2025, Q4 2024, and Q3 2024 respectively.